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ABSTRACT The outer membrane of Gram-negative bacteria presents a signiﬁcant
barrier for molecules entering the cell. Nevertheless, colicins, which are antimicrobial
proteins secreted by Escherichia coli, can target other E. coli cells by binding to cell
surface receptor proteins and activating their import, resulting in cell death. Previous
studies have documented high rates of nonspeciﬁc resistance (insensitivity) of vari-
ous E. coli strains toward colicins that is independent of colicin-speciﬁc immunity
and is instead associated with lipopolysaccharide (LPS) in the outer membrane. This
observation poses a contradiction: why do E. coli strains have colicin-expressing plas-
mids, which are energetically costly to retain, if cells around them are likely to be
naturally insensitive to the colicin they produce? Here, using a combination of trans-
poson sequencing and phenotypic microarrays, we show that colicin insensitivity of
uropathogenic E. coli sequence type 131 (ST131) is dependent on the production of
its O-antigen but that minor changes in growth conditions render the organism sen-
sitive toward colicins. The reintroduction of O-antigen into E. coli K-12 demonstrated
that it is the density of O-antigen that is the dominant factor governing colicin in-
sensitivity. We also show, by microscopy of ﬂuorescently labelled colicins, that
growth conditions affect the degree of occlusion by O-antigen of outer membrane
receptors but not the clustered organization of receptors. The result of our study
demonstrate that environmental conditions play a critical role in sensitizing E. coli
toward colicins and that O-antigen in LPS is central to this role.
IMPORTANCE Escherichia coli infections can be a major health burden, especially
with the organism becoming increasingly resistant to “last-resort” antibiotics such as
carbapenems. Although colicins are potent narrow-spectrum antimicrobials with po-
tential as future antibiotics, high levels of naturally occurring colicin insensitivity
have been documented which could limit their efﬁcacy. We identify O-antigen-
dependent colicin insensitivity in a clinically relevant uropathogenic E. coli strain and
show that this insensitivity can be circumvented by minor changes to growth condi-
tions. The results of our study suggest that colicin insensitivity among E. coli organ-
isms has been greatly overestimated, and as a consequence, colicins could in fact be
effective species-speciﬁc antimicrobials targeting pathogenic E. coli such as uro-
pathogenic E. coli (UPEC).
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Bacteria exist in complex communities across a wide range of environments,where the limitation of nutrients such as iron, amino acids, and carbon sources
drives competition for survival. In response to such coexistence, bacteria have
evolved an arsenal of proteinaceous competition systems, such as colicins, which
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are proteins secreted by Escherichia coli that kill closely related strains (1). Colicins
have a number of properties that make them promising future antimicrobials (2, 3).
They are extremely potent; they are active at picomolar concentrations and they are
highly species speciﬁc, which reduces off-target effects that would otherwise cause
dysbiosis (4, 5).
Colicins hijack cell envelope proteins in order to translocate into a cell (1). The
archetypal colicin (colicin E9) ﬁrst binds to an outer membrane receptor (BtuB) before
using an intrinsically unstructured domain to thread through the porin OmpF and
contact TolB in the periplasm. The Tol complex is then thought to activate colicin
import across the outer membrane (OM) in a proton motive force-dependent manner
(1, 6, 7). Colicin E9 delivers a DNase toxin to the cytoplasm through a poorly understood
interaction with FtsH (8).
The OM is a deﬁning feature of Gram-negative bacteria and acts as a selective
permeability barrier, limiting the passage of both hydrophilic and hydrophobic mole-
cules (9). For antibiotics, including bacteriocins, the outer membrane presents a formi-
dable barrier (10). The asymmetric outer membrane contains phospholipid within its
inner leaﬂet, while the outer leaﬂet consists of lipopolysaccharide (LPS), which has roles
in permeability, antibiotic resistance, cell adhesion, and virulence (11–13). LPS has three
moieties: lipid A, core oligosaccharides, and the O-antigen. The length of the O-antigen
varies considerably between strains depending on the number and size of repeating
units; in E. coli, the O-antigen length can vary between 17 and 37 nm depending on the
serotype (14).
The O-antigen is not essential and is often lacking in laboratory strains of E. coli, such
as K-12. During adaptation to laboratory growth, E. coli K-12 acquired the rfb-50
mutation through an IS5 insertion in the wbbL gene, which encodes a rhamnosyltrans-
ferase (15), resulting in the complete loss of O-antigen and presentation of the rough
phenotype. Spontaneous mutations that cause a loss of O-antigen confer sensitivity to
colicins, and the length of the O-antigen is known to impact colicin sensitivity (16, 17).
A survey of E. coli isolates across multiple culture libraries identiﬁed high levels of
resistance toward colicins when tested, with 70% of isolates resistant to a single
colicin and 30% of strains resistant to a panel of 18 colicins (18). Despite the high
levels of resistance observed under laboratory conditions, colicin plasmids are wide-
spread across E. coli (10% to 50%) (19). Moreover, colicins have been shown to have an
antimicrobial affect against multiple E. coli strains, including uropathogenic E. coli
(UPEC) (20).
Approximately 150 million people suffer from urinary tract infections (UTI) each year,
of which 75% are caused by UPEC strains (21). A clone of E. coli (sequence type 131
[ST131]) identiﬁed in 2008 as resistant to ﬂuoroquinolones and positive for CTX-M-15
extended-spectrum -lactamases is now recognized as a globally disseminated strain
and a major lineage within extraintestinal E. coli (ExPEC) (22). UPEC ST131 has become
a multidrug-resistant bacterium and a major cause of UTI, particularly in the health care
setting (23).
The presence of colicin-expressing plasmids across multiple E. coli strains presents a
paradox, since high levels (70%) of colicin insensitivity are typically observed in the
lab (18, 24). Yet, some colicins have been found associated with UPEC strains and have
even been proposed as virulence factors (25, 26). Here, we distinguish between speciﬁc
colicin resistance, through mutations of, for example, colicin receptors, and colicin
insensitivity, which is a nonspeciﬁc phenotype associated with the cell surface. We
show that UPEC ST131 is insensitive to colicins in an O-antigen-dependent manner and
that insensitivity can be introduced into K-12 strains by restoring the O-antigen.
Critically, however, while O-antigen provides high levels of nonspeciﬁc insensitivity, it
is dependent on growth conditions and, as such, provides an explanation as to why
colicin-expressing plasmids are present in smooth E. coli strains but are not seemingly
active against strains when assayed under lab conditions.
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RESULTS AND DISCUSSION
UPEC ST131 is insensitive to multiple colicins. UPEC ST131 exposed to colicin E9
showed a 6,000-fold difference in MIC compared to that of the colicin-sensitive E. coli
K-12 strain JM83 when tested on solid medium and a 1,000-fold higher MIC in liquid
culture (LB medium) (Fig. 1). Resistance to colicins is typically associated with a cognate
immunity protein or mutations in receptor/translocator proteins (1, 27). To test whether
these mechanisms were responsible for the observed resistance, UPEC ST131 was
exposed to different colicins. The chosen colicins target different receptors/transloca-
tion proteins (ColIa, Cir; ColD, FepA; ColE9, BtuB/OmpF), encompassing both the Tol
(group A colicins) and the Ton (group B colicins) complexes, and kill the target cell via
different mechanisms, including via the depolarization of the cytoplasmic membrane
and nucleolytic activity in the cytoplasm (ColIa, pore forming; ColD, tRNase; ColE9,
DNase). UPEC ST131 had a 10,000-fold higher MIC of ColIa compared to that of E. coli
JM83 and was unaffected by colicin D at the highest concentration tested (10 M) (see
Fig. S1 in the supplemental material). A genome analysis of UPEC ST131 did not identify
signiﬁcant similarity to colicin immunity protein genes for any of the colicins tested,
suggesting that mutations in receptors or the presence of immunity proteins is not
responsible for the resistance and that UPEC ST131 has a nonspeciﬁc mechanism which
causes insensitivity to colicin.
To determine if insensitivity toward colicins is a widely observed phenomenon
across UPEC strains, 10 UPEC strains were exposed to ColE9 to determine the MICs. Six
of the ten strains were not affected by ColE9 at concentrations up to 10 M (see Tables
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FIG 1 Solid and liquid medium killing assays of UPEC ST131 and colicin-sensitive E. coli JM83 exposed to puriﬁed ColE9. (Top) Solid medium killing assays on
LB agar using serial dilutions of ColE9. UPEC ST131 shows slight sensitivity to the highest concentrations of ColE9, whereas E. coli JM83 is sensitive at picomolar
concentrations. (Bottom) Liquid medium killing assay using LB. UPEC ST131 had a 1,000-fold higher MIC than JM83.
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S1 and S2). The four susceptible isolates had MICs for ColE9 between 30-fold and
2,000-fold higher than the sensitive E. coli MG1655 strain.
LPS and O-antigen biosynthesis genes are associated with colicin insensitivity.
To elucidate the genetic basis for colicin insensitivity in UPEC ST131, a transposon-
directed insertion sequencing (TraDIS) approach was used. TraDIS is a powerful tech-
nique to assay the ﬁtness contribution of genes across an entire genome (28). A TraDIS
transposon library for UPEC ST131, NCTC 13441, was established using the method
described previously (29, 30). The library had a high insertion density, with 450,000
unique insertion sites across the 5.4-Mbp genome, giving an average density of 1
insertion per 12 bp, allowing for an accurate and sensitive evaluation of the role of each
gene in colicin insensitivity (barring those which appear essential under these condi-
tions). To test for a role in colicin insensitivity, two samples of the transposon library
were prepared: one sample was exposed to a sub-MIC of ColE9 (0.5 nM) and the other
was treated with buffer. Genes which provide insensitivity will have a reduced number
of transposon insertions compared to that of a control sample, as insertions would
disrupt that gene and stop the production of a protective protein. One hundred
fourteen genes had a signiﬁcant decrease in insertions (genes normally involved in
insensitivity) compared to that in the non-colicin-treated control, and 34 genes had an
increase in insertions (genes normally involved in rendering bacteria susceptible to the
colicin) (see Data Set S1). Thirty-three of the genes with decreased insertions (28%)
were mapped to ﬁve operons responsible for LPS biosynthesis, O-antigen biosynthesis,
enterobacterial common antigen (ECA) biosynthesis, membrane lipid asymmetry, and
lipid A modiﬁcation.
The presence of the O-antigen has been shown to provide insensitivity to colicins in
some E. coli backgrounds but not for UPEC ST131 (16). Nine of the genes with a role in
nonspeciﬁc colicin insensitivity are annotated with functions associated with O-antigen
production and have been shown to decrease sensitivity toward SDS and serum (31).
We also identiﬁed seven core LPS genes with roles in colicin insensitivity, in keeping
with the O-antigen being attached to core LPS. O-antigen is ligated to core LPS via the
O-antigen ligase RfaL, which we also found to be associated with colicin insensitivity.
Additionally, rfaH, the LPS biosynthesis regulator, was also identiﬁed as providing an
increase in ﬁtness in the presence of colicin. Four genes of the arn operon, involved in
the modiﬁcation of lipid A, were also found to be required for colicin insensitivity. The
arn operon is involved in resistance to cationic antimicrobial peptides (CAMPs) by
increasing the net positive charge of lipid A in the OM through the addition of a
4-amino-4-deoxy-L-arabinose (L-Ara4N) moiety (32). The PhoPQ two-component system
is required for activation of the arn operon, and both of these components were
highlighted as being involved in colicin insensitivity. Increases in L-Ara4N have been
shown to increase resistance to polymyxins in Salmonella enterica serovar Typhimurium
and Klebsiella pneumoniae (33). The mla operon encodes an ATP transporter that is
responsible for maintaining the asymmetry of the OM, and mutation of the mla genes
has been demonstrated to cause sensitivity to SDS and EDTA (34). In addition to the
overrepresentation of genes involved in ﬁve OM-related operons, we identiﬁed 12
genes which had no obvious role in OM stability from their annotation but were shown
to have a role in serum resistance in E. coli ST131 (31, 35). Though seven genes from the
ECA biosynthesis operon were highlighted by TraDIS, these genes may have roles in
O-antigen biosynthesis, and the role of ECA in colicin insensitivity is still to be deter-
mined (36). Genes which increased colicin E9 susceptibility included, as expected, those
for its receptor and translocator proteins, btuB and ompF, respectively. Two genes
involved in formation of the core LPS, rfaQ and rfaY, were also identiﬁed as increasing
colicin susceptibility. Though these genes were not previously identiﬁed as necessary
for sensitivity to colicins, a positive role of the core LPS in colicin activity has been
identiﬁed for colicins N and A (37).
Destabilizing the LPS decreases nonspeciﬁc insensitivity toward colicin. The
TraDIS analysis highlighted a signiﬁcant role for the O-antigen in colicin insensitivity. To
test this, we used EDTA to destabilize the LPS packing and assayed for an increase in
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colicin sensitivity. EDTA destabilizes LPS packing by chelating divalent cations which
stabilize adjacent lipid A molecules (38). The introduction of EDTA into the growth
medium for UPEC ST131 reduced the MIC for three bacteriocins by 10,000-fold for ColIa
and 100-fold for ColE9 (see Fig. S2). UPEC ST131 also became sensitive toward ColD at
10 M, whereas it previously showed no activity. Repeating the TraDIS analysis in the
presence of EDTA (in the media for both the colicin-treated and control pools) revealed 21
genes associated with colicin insensitivity. These genes were all involved in LPS biosynthe-
sis, O-antigen biosynthesis, ECA biosynthesis, and lipid A modiﬁcation (Table 1).
O-antigen-restored E. coli K-12 is colicin insensitive. To test directly the effect of
the O-antigen on colicin sensitivity, we used strains of E. coli K-12 MG1665 which have
a restored O-antigen (39) (Table 2). Henderson and coworkers restored the wbbL gene
in E. coli K-12 MG1655 to give rise to two strains: L9 with a wild-type (WT) gene order
and L5 with incorrect synteny and a signiﬁcant (10-fold) decrease in O-antigen (39).
Both MG1655 and the L5 derivative were sensitive to multiple colicins, whereas the L9
strain, with its fully restored O-antigen, was insensitive to 10 M ColE9 (100,000-fold
increase in MIC) on solid medium and insensitive up to 250 nM ColE9 in liquid medium
(5,000-fold increase in MIC) (Fig. 2). L5 and L9 strains differ only in the densities of
O-antigen, demonstrating that the presence of O-antigen is not sufﬁcient to generate
colicin insensitivity but that the density of O-antigen is the critical factor for the
100,000-fold increase in MIC. The LPS core has previously been reported as aiding the
translocation of colicins N and A (37). These colicins still had a greatly reduced activity
toward the L9 strain compared to that toward the L5 strain (see Fig. S3).
TABLE 1 Genes highlighted by TraDIS as providing a ﬁtness beneﬁt to UPEC ST131 in the presence of colicinsa
Gene name Function of product logFCb q value Accession no.
0061 LPS core heptosyltransferase 12.149 1.06E235 WP_001236430.1
rfaG_1 LPS core glycosyltransferase 2.088 4.55E029 WP_000634259.1
rfaH Transcription factor involved in LPS biosynthesis 4.842 1.10E056 WP_001192400.1
rfaJ_2 LPS core glycosyltransferase 8.354 0 WP_000376840.1
rfaJ_1 LPS core 3-alphagalactosyltransferase 7.005 0 WP_001188027.1
rfaL O-antigen ligase 5.297 0 WP_000958045.1
rfbC Rhamnose-speciﬁc dTDP-4-dehydrorhamnose-3,5-epimerase 11.967 2.07E158 WP_001100793.1
lacA_1 WbbJ; catalyzes the transfer of the O-acetyl moiety to the O-antigen 10.953 1.24E105 WP_001296213.1
rfbD dTDP-glucose-4,6-dehydratase 10.919 0 WP_000699407.1
wbbL Glycosyltransferase 10.651 9.64E080 WP_000262536.1
rfaG_2 LPS core glycosyltransferase 9.977 9.71E214 WP_001296214.1
01679 Hypothetical protein 9.190 1.26E153 WP_000027654.1
01681 Glycosyltransferase 6.985 2.70E036 WP_000517629.1
rfbB Rhamnose-speciﬁc dTDP-glucose-4,6-dehydratase 3.545 0 WP_000699407.1
rmlA1 Rhamnose-speciﬁc glucose-1-phosphate thymidylyltransferase 2.980 0 WP_000857525.1
wecA ECA transferase 7.915 0 WP_001050960.1
04729 Putative common enterobacterial antigen polymerase 7.360 5.76E048 WP_000055112.1
wzxE ECA ﬂippase 4.547 1.14E064 WP_000050265.1
arnE Lipid A modiﬁcation (CAMP resistance) ﬂippase subunit 2.413 1.86E021 WP_000638016.1
arnD Lipid A modiﬁcation (CAMP resistance) deformylase 2.271 1.82E080 WP_000169713.1
02987 Hypothetical protein 1.960 9.74E009 WP_001295929.1
aResults are in the presence of EDTA.
bDifferences in insertions between the control and colicin-treated sample are measured as a log fold change (logFC).
TABLE 2 Strains used in this study
Strain Description Source or reference
E. coli BL21(DE3) fhuA2 [lon] ompT gal () [dcm] ΔhsdS  DE3   sBamHIo ΔEcoRI-B
int::(lacI::PlacUV5::T7 gene 1) i21 Δnin5
New England BioLabs
E. coli NEB 5 fhuA2 Δ(argF-lacZ)U169 phoA glnV44 80 Δ(lacZ)M15
gyrA96 recA1 relA1 endA1 thi-1 hsdR17
New England BioLabs
E. coli MG1655 F  ilvG rfb-50 rph-1
E. coli JM83 F ara Δ(lac-proAB) rpsL (Strr) [80 dlacΔ(lacZ)M15] thi
E. coli DFB1655 L5 (L5) MG1655 with pJP5603/wbbL inserted into rfb gene cluster 39
E. coli DFB1655 L9 (L9) MG1655 with pJP5603/wbbL inserted into rfb gene cluster 39
E. coli UPEC ST131 (NCTC 13441) CTX-M-15 ESBL
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Colicin insensitivity in UPEC ST131 is dependent on growth conditions. The L5
and L9 strains showed that changes in the densities of O-antigen can render bacteria
sensitive to colicin. Conversely, destabilization of the LPS packing in the outer mem-
brane by EDTA treatment causes an increase in colicin sensitivity. Given these impacts
on colicin sensitivity, we set out to determine if growth conditions inﬂuenced colicin
sensitivity. Bacteria occupy a wide variety of environmental niches and, as a result, are
exposed to different conditions and stresses which could inﬂuence the density of
O-antigen and therefore colicin sensitivity. Biolog phenotypic microarrays were used to
study respiration in the presence and absence of sub-MIC ColE9 across hundreds of
different growth conditions (40). Four plates were investigated: two screened various
carbon sources, one explored a range of pHs with different additives, and a ﬁnal plate
varied osmolytes and osmolarity (see Data Set S2).
No difference in colicin sensitivity was observed for any of the altered carbon source
conditions (191 different conditions). However, colicin sensitivity was found to be
dependent on osmolarity and pH. Concentrations of NaCl of0.68 M caused sensitivity
to ColE9 at 41 nM (one-third MIC of ColE9 in Biolog inoculation medium), and sodium
lactate (0.62 M) and KCl (0.4 M) had similar effects. Interestingly, UPEC ST131 was
sensitive to sub-MIC ColE9 in the presence of urea. UPEC ST131 was also sensitive to
ColE9 at alkaline pH (pH 8). We therefore decided to validate two conditions: Tris and
urea. Tris is a commonly used buffer, but it is also known to trigger the release of LPS
from the OM (41). Urea was chosen as it is present in the urinary tract as the major
constituent of urine (150 to 500 mM) (42). UPEC ST131 and the O-antigen-presenting
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FIG 2 Restoration of the O-antigen in E. coli MG1655 provides insensitivity to a variety of colicins. (a) E.
coli strains were exposed to colicins ColIa, ColD, and ColE9, which target different receptor and
translocation proteins. (b) Liquid medium killing assay using 50 nM ColE9.
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L9 strain were challenged with a sub-MIC of ColE9 (33 nM) in the presence/absence of
Tris (100 mM [pH 7.2]) or a physiological concentration of urea (150 mM).
The two strains have different O-antigen serotypes (L9, O16; UPEC ST131, O25b) and
behave differently under the conditions tested. UPEC ST131 was sensitive to the sub-MIC
of ColE9 in the presence of urea and Tris, conﬁrming the Biolog results. In contrast, the L9
strain was only sensitive in the presence of Tris. This may indicate that the L9 strain is
producing a denser O-antigen than UPEC ST131 and Tris is a better agent for LPS removal
or that UPEC ST131 O-antigen is particularly affected by urea (Fig. 3).
Dense O-antigen diminishes colicin receptor binding. Translocation of ColE9
across the outer membrane involves binding to an outer membrane receptor (BtuB)
before threading an unstructured domain through OmpF to contact the Tol system in
the periplasm (6, 43). O-antigen might provide insensitivity by blocking the binding of
ColE9 to its receptor or by preventing the unstructured domain from threading through
OmpF. To distinguish between these possibilities, ColE9 binding to BtuB on the surfaces
of target bacteria in the presence and absence of O-antigen was investigated by
ﬂuorescence microscopy, using Alexa Fluor 647-labeled ColE9 (44).
A statistically signiﬁcant difference was observed between the L5 and L9 strains: L5
displayed clear colicin binding, whereas no colicin binding was observed for L9
(Student’s t test, P 0.01) (Fig. 4). Tris, which decreases the MIC of colicins for both the
L9 strain and UPEC ST131, was evaluated to test if a decrease in MIC correlated with an
increase in receptor binding. No differences were observed in colicin binding for the L5
strain in the presence or absence of Tris, suggesting that receptor binding is saturated
and the presence of low-density O-antigen is not sufﬁcient to block colicin binding. The
addition of Tris caused a signiﬁcant increase in receptor binding for both the L9 and
UPEC ST131 strains. No signiﬁcant difference was observed in the intensities between
the L5 strain and the L9 strain with addition of Tris, suggesting that 100 mM Tris is
sufﬁcient to remove any protection afforded by the O-antigen. Urea was not used as a
condition for microscopy, as it greatly increased background ﬂuorescence.
Previous studies using ﬂuorescently labeled colicins have shown that outer mem-
brane proteins (OMPs) cluster into supramolecular assemblies termed OMP islands in E.
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FIG 3 Addition of urea and Tris increases sensitivity toward ColE9 (33 nM) in strains with an O-antigen. (a)
Addition of physiological concentrations of urea (150 mM) increased the sensitivity of UPEC ST131 to ColE9
but not that of the E. coli L9 strain. (b) Addition of 100 mM Tris decreased the MICs of ColE9 for both UPEC
ST131 and E. coli L9.
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coli lacking O-antigen, which might have effects on the accessibility of OMPs (44, 45).
We therefore set out to determine if O-antigen affected this clustering behavior. Using
total internal-reﬂection ﬂuorescence (TIRF) microscopy, we observed OMP islands in the
MG1655, L5, and UPEC strains (Fig. S3). The L9 strain could not be validated for the
presence of OMP islands, as colicin did not bind BtuB under the conditions tested.
Concluding remarks. The presence of O-antigen in the bacterial outer membrane
has been linked to nonspeciﬁc insensitivity toward colicin, phages, and complement
(17, 46). Moreover, the length of O-antigen affects colicin insensitivity in Shigella (17).
The difference in colicin sensitivity between the E. coli L5 and L9 strains in the present
study, coupled with the observation that Tris and EDTA render cells more sensitive to
colicin, suggests that subtle changes in the density of O-antigen have signiﬁcant effects
on colicin sensitivity. High levels of colicin resistance across E. coli collections have been
observed under lab conditions. Bacteria in the environment will be subjected to a range
of stresses and insults to the OM and are unlikely to have an O-antigen as dense as that
under laboratory conditions, meaning the scale of colicin insensitivity is likely overes-
L5 L9 UPEC
+++ ---Tris
DIC
Alexa
Fluor
647
a
b
NS
FIG 4 Fluorescently labeled ColE9 shows difference in receptor binding dependent on the density of
O-antigen. (a) Colicin E9 labeled with Alexa Fluor 647 (red) was used to visualize the extent of BtuB
binding in the OM (45). Scale bar, 5 m. (b) O-antigen-producing L5 and L9 mutants were compared to
UPEC ST131 by exposure to ﬂuorescently labeled ColE9 in LB medium (green) or LB medium supple-
mented with 100 mM Tris (orange). Each point represents the average ﬂuorescence intensity over a single
cell. Statistically signiﬁcant differences in labeling were observed between the isogenic L5 and L9 strains
(t test). Addition of 100 mM Tris-HCl caused signiﬁcant increases in cell labeling for both the L9 strain and
UPEC ST131.
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timated. This also suggests that such nonspeciﬁc colicin insensitivity could change
depending on the environment, host infection site, and stage of infection. For example,
during a chronic infection, Pseudomonas aeruginosa loses its O-antigen, while Burk-
holderia dolosa gains the ability to produce O-antigen (47). For UPEC ST131, the
sensitivity toward colicin in the presence of urea presents an intriguing possibility.
Uropathogenic E. coli is transmitted to a new host by fecal-oral contamination before
mechanical transmission to the urinary tract from the anus (48). UPEC bacteria could
therefore be resistant to colicin in the gut, where they will be surrounded by other E.
coli, but become sensitive to colicin in the urinary tract, a relatively sterile environment
where bacteria would face less competition. It therefore becomes possible that colicins
could be an effective treatment for UTI while not affecting commensal E. coli.
Colicin-like proteins are found throughout Gammaproteobacteria (24). To date,
O-antigen dependent insensitivity has only been studied using colicins. As the
O-antigen varies between strains, so may its ability to protect against receptor binding.
The O-antigen is not the only structure present at the OM, many bacteria produce a
capsule, a thick layer of polysaccharide which can protect against antimicrobial proteins
and has been associated with virulence (49). The thickness of this capsule varies greatly
between species (E. coli, 10 nm; K. pneumoniae, 160 nm) and could be a signiﬁcant
barrier for colicin receptor binding (50).
Many studies, both theoretical and experimental, have indicated roles for colicins in
bacterial competition and in maintaining a diverse microbial community (51, 52).
However, it is possible that colicins also have another purpose. In a mixed microbial
community of colicin-producing and colicin-insensitive (due to O-antigen) bacteria, the
basal level of colicin production would act as a selective pressure to ensure bacteria
maintain their O-antigen, increasing the ﬁtness of the overall population.
In summary, we solve the problem of why smooth E. coli harbor colicin plasmids
yet appear insensitive toward colicins when assayed under laboratory conditions.
O-antigen-dependent colicin insensitivity was observed for UPEC ST131, a clinically
important pathogen. Using isogenic O-antigen mutants, we found that the density of
the O-antigen is important for colicin sensitivity. Additives that cause shedding of LPS
decreased the MIC of colicins for insensitive strains, suggesting that environmental
factors inﬂuence the density of O-antigen and hence sensitivity toward colicin.
MATERIALS AND METHODS
Colicin expression and puriﬁcation. Colicin E9 Im9(His)6, colicin E9 (H551A K469C) Im9(His)6 (53),
colicin Ia ImIa(His)6, and colicin D ImD(His)6 were puriﬁed from BL21(DE3) cells induced with isopropyl-
-D-thiogalactopyranoside (IPTG). Proteins were ﬁrst puriﬁed by Ni-afﬁnity chromatography using a 5-ml
HisTrap HP column (GE Healthcare) and eluted using a 0-to-250 mM imidazole gradient. After dialysis
overnight against 25 mM Tris-HCl (pH 7.5) and 150 mM NaCl, the protein was further puriﬁed by size
exclusion chromatography using a HiLoad 26/60 Superdex 200 column (GE Healthcare) equilibrated in
25 mM Tris-HCl (pH 7.5) and 150 mM NaCl with the addition of 10 mM dithiothreitol (DTT) for the ColE9
cysteine mutant to prevent dimerization.
Solid medium killing assay. Soft LB agar (0.7% [wt/vol)] was inoculated (1:25) with a culture of the
indicator strain (optical density at 600 nm [OD600] of 0.4) and overlaid onto LB agar (1.5% [wt/vol]).
Serial dilutions of colicins were prepared using 20 mM Tris-HCl (pH 7), and 2 l was spotted onto the
agar. Plates were incubated overnight at 37°C, and the MIC was deﬁned as the lowest concentration at
which a zone of clearance in the soft agar was observed.
Liquid medium killing assay. Overnight cultures of the strains E. coli MG1655, E. coli L5, E. coli L9,
and UPEC ST131 were used to inoculate (1:100) 10 ml fresh medium supplemented as appropriate and
cultured at 37°C until cultures reached an OD600 of 0.4. Cultures were then diluted (1:3, 200 l) in a
ﬂat-bottomed 96-well plate in triplicates containing medium supplemented with the appropriate addi-
tive with or without the addition of colicin. Growth was monitored by measuring the OD600 using the
Clariostar high-performance microplate reader, and MIC was deﬁned as the concentration at which
50% of growth was inhibited).
TraDIS library generation, testing, and analysis. The UPEC ST131 (NCTC 13441) TraDIS library was
generated using the method previously described (29). The library was cultured overnight at 37°C in
MMTE medium (morpholinepropanesulfonic acid [MOPS] minimal medium with KPO4, 1 mM EDTA,
100 mM Tris-HCl [pH 8], and 0.2% [wt/vol] glucose) or MMT medium (MOPS minimal medium with KPO4,
100 mM Tris-HCl [pH 8], and 0.2% [wt/vol] glucose) with 0.5 nM ColE9 Im9(His)6 or without colicin.
Overnight cultures were used to inoculate fresh identical media 1:10 and cultured overnight at 37°C. DNA
was extracted from the passaged culture and sequenced using the Illumina HiSeq 2500 platform.
Insertions were analyzed using the BioTraDIS pipeline, a pearl library with a host of tools for TraDIS
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analysis (30). Only reads which contained the transposon tag were considered for analysis. Twenty reads
per insertion was considered signiﬁcant, and reads within 10% of the 3= end of the open reading frame
were ignored, as these insertions may not disrupt protein function (54). A log fold change of 2 with a
false-discovery rate (q value) of 0.00005 was used as a signiﬁcant threshold.
Biolog. Biolog phenotypic microarrays (PM) monitor the respiration of bacteria across different
growth conditions by measuring the reduction of a tetrazolium-based dye (40). Four PM plates were
selected for testing: PM1 and PM2, which test different carbon sources; PM9, which tests the effects of
osmolytes; and PM10, which tests a range of pH values. UPEC ST131 was cultured overnight in MMTE
medium at 37°C overnight with shaking and was used to inoculate the inoculation ﬂuid used in Biolog.
Colicin E9 Im9(His)6 was added to the PM plates, and as a control, an inactive colicin, which lacks the
unstructured region at the N terminus and contains a disulﬁde bond which does not allow for the
conformational change needed for translocation, was used to test for UPEC ST131 respiration without
the effect of a cytotoxic colicin (55). Inoculated PM plates were observed by using an OmniLog incubator
and reader for 48 h, measuring absorbance every 15 min. Biolog absorbance data were analyzed using
the DuctApe PM analysis suite (56). DuctApe measures nine parameters and performs K-means clustering
to assign each curve an activity index. Differences between the active- and inactive-colicin-treated
clusters were calculated.
Microscopy and image analysis. For ﬂuorophore labeling, site-directed mutagenesis was used to
incorporate a cysteine into ColE9 (H551A K469C) or ColE9 K469C with an N-terminal deletion, Δ2-62, which
is known to block import into cells (44). Puriﬁed protein was labeled with Alexa Fluor 647 (AF647). AF647
with an exposed maleimide group was covalently linked to the sulfhydryl of the engineered cysteine to
form a stable conjugate. Excess dye was removed by passing the protein through a Superdex 75 10/300
column (GE Healthcare).
E. coli L5, E. coli L9, and UPEC ST131 were incubated overnight at 37°C with shaking in LB medium.
Overnight cultures were used to inoculate (1:100) LB medium with additives and were incubated at 37°C
until an OD600 of 0.4 was reached. From each sample, 1,600 l was pelleted by centrifugation at
7,000 g for 3 min, and the pellet was resuspended in 200 l of 1.5 M ColE9 and incubated for 30 min
with rotary inversion at room temperature. Cells were washed three times in 400 l of LB with the
additive of interest. Cells were resuspended in approximately 200 l of medium, and 10 l of cells was
placed onto a 1% agar pad. Fluorescence was visualized by wideﬁeld microscopy using the DeltaVision
OMX V3 system. Images were acquired following excitation at 642 nm for 50 ms and processed using Fiji
image processing software (57). Student’s t tests were used to identify statistically signiﬁcant differences
between treatment and strains.
Accession number(s). TraDIS sequencing data are available under the accessions ERS939266 to
ERS939273 and ERS441440 to ERS441443. Other data supporting this study can be found within the
article and the supplemental material or requested from the corresponding author.
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